Literature DB >> 30711450

Mitigation of ER-stress and inflammation by chemokine (C-C motif) ligand 21 during early pregnancy.

Hyocheol Bae1, Whasun Lim2, Fuller W Bazer3, Kwang-Youn Whang4, Gwonhwa Song5.   

Abstract

The immune system plays an important role in pregnancy. Chemokines recruit leukocytes at the maternal-fetal interface during early pregnancy. However, the role of the chemokine, C-C motif chemokine ligand 21 (CCL21), is less known. The aim of this study was to identify the expression of CCL21 and its receptor, CCR7, in the endometrium during estrous cycle and early pregnancy, and to investigate the functional effects of CCL21 on porcine trophectoderm (pTr) and porcine uterine luminal epithelial (pLE) cells. Our results indicated that CCL21 and CCR7 are increased in the glandular (GE) and luminal epithelium (LE) of the endometrium during early pregnancy, compared to estrous pigs. Recombinant CCL21 improved pTr and pLE cell proliferation through activation of the PI3K and MAPK pathways and suppression of tunicamycin-induced endoplasmic reticulum (ER) stress or LPS-induced inflammation. Collectively, these results provide novel insights into CCL21-mediated signaling mechanisms at the maternal-fetal interface during early pregnancy.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CCL21; CCR7; Development; Pigs; Pregnancy; Uterus

Mesh:

Substances:

Year:  2019        PMID: 30711450     DOI: 10.1016/j.dci.2019.01.016

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  2 in total

1.  The benefits of higher LMR for early threatened abortion: A retrospective cohort study.

Authors:  Qiu-Ting Feng; Chi Chen; Qing-Ying Yu; Si-Yun Chen; Xian Huang; Yan-Lan Zhong; Song-Ping Luo; Jie Gao
Journal:  PLoS One       Date:  2020-04-20       Impact factor: 3.240

2.  Pyrimidine-5-carbonitrile based potential anticancer agents as apoptosis inducers through PI3K/AKT axis inhibition in leukaemia K562.

Authors:  Nehad M El-Dydamony; Rana M Abdelnaby; Rasha Abdelhady; Omaima Ali; Mohamed I Fahmy; Rasha R Fakhr Eldeen; Amira A Helwa
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.